Neuvivo
is headquartered in Palo Alto, California. Ari Azhir is the CEO of Neuvivo. Neuvivo has received a total of $11M in funding. Neuvivo has 1 followers on Owler.Neuvivo
is headquartered in Palo Alto, California. Ari Azhir is the CEO of Neuvivo. Neuvivo has received a total of $11M in funding. Neuvivo has 1 followers on Owler.
News
Jan 23, 2025
Business Wire
Press Release: Neuvivo : Mounting Evidence Demonstrates Neuvivo's NP001 Spares Lung Function and Substantially Extends Survival in ALS Patients
Oct 17, 2024
StreetInsider
Press Release: Neuvivo : Significant Breakthroughs in Preserving ALS Lung Function and Survival Unveiled in Peer-Reviewed Studies of Novel Immunotherapy Platform NP001
Oct 08, 2024
Pharmaceutical Business Review
Neuvivo: Neuvivo files NDA seeking FDA approval for ALS treatment
Oct 07, 2024
Pharamceutical Technology
Neuvivo: Neuvivo makes bid to enter ALS arena with immunotherapy candidate
Aug 23, 2024
PR Newswire
Press Release: Neuvivo : Neuvivo Announces Mark Henderson, PhD, as Vice President of Manufacturing to Support Technical Operations for Investigational ALS Treatment
Aug 22, 2024
Contract Pharma
Neuvivo: Pharmaceutical Industry Veteran Joins Neuvivo
Jun 26, 2023
Global Legal Chronicle
Neuvivo: Neuvivo's $11 Million Financing Round
Jun 15, 2023
BioSpace
Neuvivo: Neuvivo Raises $11M in Venture Financing to Develop Treatment for ALS
Dec 01, 2022
PR Newswire
Press Release: Neuvivo : Neuvivo's NP001 for Treatment of ALS Slows Disease Progression Through Regulation of Microbial Translocation
Jun 20, 2022
FirstWord Pharma
Neuvivo: Neuvivo Adds Former FDA Chief Counsel Peter Barton Hutt as Advisor